Devices › Catheter, angioplasty, peripheral, transluminal
Device brand name · Pta balloon dil catheter
Ultra-Thin Balloon Dilatation Catheter: medical device reports filed with FDA
488 reports name it, 1996–2010. Manufacturer given most often on reports: Medi-Tech A Division Of Boston Scientific. Product code LIT.
- 488
- device reports naming the brand
- 0% of all MAUDE reports · about 16 a year
- 0
- reports, 12 months to August 2026
- 0 in the 12 months before
- 59.2%
- classified as malfunction
- 83.5% across the product code
- 0.4%
- classified as death, as reported
- 2 reports · not verified by FDA
488 medical device reports received by FDA name the brand "Ultra-Thin Balloon Dilatation Catheter" (pta balloon dil catheter); the manufacturer given most often on reports is Medi-Tech A Division Of Boston Scientific; received from August 1996 to December 2010. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.
0 reports arrived in the 12 months to August 2026, and none in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (59.2%), injury (40.2%) and death (0.4%); across all catheter, angioplasty, peripheral, transluminal reports (product code LIT) death is recorded in 0.5% and malfunction in 83.5%. Event type is the reporter's classification of the report, not a verified outcome.
The device problems coded most often are balloon rupture (53.1%), source, detachment from (29.5%) and difficult to remove (22.7%). The patient problems coded most often are foreign body, removal of, surgical procedure and surgical procedure, additional. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Reports by month, five years
No report naming Ultra-Thin Balloon Dilatation Catheter was received in the five years to August 2026; the latest was received in December 2010.
By year received
Event type and report source
Event type, as classified on the report
Who filed the report
Grey bar: all 35,907 reports carrying product code LIT. Event type is the filer's classification and is not verified by FDA.
Device problems coded
| Device problem (FDA code) | Reports | Share | Share across product code |
|---|---|---|---|
| Balloon rupture | 259 | 53.1% | 7.4% |
| Source, detachment from | 144 | 29.5% | 0.9% |
| Difficult to removethe device was hard to remove | 111 | 22.7% | 9.1% |
| Calcified | 109 | 22.3% | 0.5% |
| Detachment of device component | 87 | 17.8% | 2.7% |
| Replace | 60 | 12.3% | 3.5% |
| Balloon burst | 44 | 9% | 3.2% |
| Balloon leak(s) | 44 | 9% | 0.7% |
| Device, or device fragments remain in patient | 39 | 8% | 0.7% |
| Increase in pressure | 31 | 6.4% | 0.1% |
| Physical resistance | 26 | 5.3% | 0.8% |
| Deflation problem | 20 | 4.1% | 4.5% |
| Inflation problem | 18 | 3.7% | 4.1% |
| Device, removal of (non-implant) | 17 | 3.5% | 1.4% |
| Material separation | 13 | 2.7% | 2.4% |
| Sticking | 10 | 2% | 0.9% |
| Fracturea broken bone | 8 | 1.6% | 0.6% |
| Other (for use when an appropriate device code cannot be identified) | 7 | 1.4% | 0.7% |
| Migration or expulsion of device | 6 | 1.2% | 0.3% |
| Breakthe device broke | 4 | 0.8% | 3.2% |
FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.
Patient problems coded
| Patient problem (FDA code) | Reports | Share |
|---|---|---|
| Foreign body, removal of | 129 | 26.4% |
| Surgical procedure | 55 | 11.3% |
| Surgical procedure, additional | 44 | 9% |
| Nonresorbable materials, unretrieved in body | 41 | 8.4% |
| Therapy/non-surgical treatment, additional | 30 | 6.1% |
| Other (for use when an appropriate patient code cannot be identified) | 15 | 3.1% |
| Surgery, prolonged | 7 | 1.4% |
| Surgical procedure aborted/stopped | 7 | 1.4% |
| Needle stick/puncture | 4 | 0.8% |
| Perforation | 4 | 0.8% |
| Embolism | 3 | 0.6% |
| No patient involvement | 3 | 0.6% |
| Painpain, site not specified | 3 | 0.6% |
| Therapy/non-surgical treatment, aborted/stopped | 3 | 0.6% |
| Aneurysm | 2 | 0.4% |
Patient problem codes are present mainly in reports filed since 2019 and are often blank.
In context
| Measure | Ultra-Thin Balloon Dilatation Catheter | Product code LIT | All MAUDE reports |
|---|---|---|---|
| Reports | 488 | 35,907 | 26,136,888 |
| Share of that pool | — | 1.4% | 0% |
| Classified as death, per 1,000 reports | 4 | 5 | 9 |
| Classified as injury | 40.2% | 15.1% | 36.2% |
| Classified as malfunction | 59.2% | 83.5% | 62.3% |
| Filed by the manufacturer | 100% | 97.6% | 94.9% |
Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Other brands with product code LIT
| Brand | Reports | Latest 12 months | Classified as death |
|---|---|---|---|
| Coyote? ES | 5,428 | 438 | 0% |
| 2cm Peripheral Cutting Balloon | 3,202 | 314 | 0% |
| Armada 35 PTA Catheter | 1,864 | 9 | 0.2% |
| Sterling | 4,963 | 300 | 0.1% |
| Coyote? | 1,767 | 122 | 0.1% |
| Mustang | 5,969 | 491 | 0.3% |
| Armada 18 Pta Catheter | 651 | 0 | 0% |
| Armada | 680 | 305 | 0.1% |
| Gladiator? Elite | 545 | 59 | 0% |
| Armada 14 Pta Catheter | 746 | 0 | 0% |
| Fox Plus Pta Catheter | 385 | 0 | 0% |
| Ultraverse RX | 369 | 68 | 0% |
| Evercross 035 | 427 | 30 | 2.6% |
| Sterling Es Pta Balloon Dilatation Catheter | 333 | 0 | 0% |
| Fox Sv Pta Catheter | 299 | 0 | 0.3% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."
Questions about Ultra-Thin Balloon Dilatation Catheter reports
How many FDA reports name Ultra-Thin Balloon Dilatation Catheter?
488 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 0 in the latest 12 months.
What kinds of events are reported?
malfunction (59.2%), injury (40.2%) and death (0.4%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.
What device problems are coded?
balloon rupture (53.1%), source, detachment from (29.5%), difficult to remove (22.7%), calcified (22.3%) and detachment of device component (17.8%). These are FDA's device problem codes as entered on the report.
Who files these reports?
manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.
Do these reports show that Ultra-Thin Balloon Dilatation Catheter was at fault?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."
How do I report a problem with a medical device?
Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.